Sudeep Pharma Receives FDA Approval for New Gujarat Plant

Pharmaceutical company Sudeep Pharma has announced the receipt of approval from the US Food and Drug Administration (FDA) to construct a new manufacturing facility in Gujarat. The plant, once operational, will have an impressive production capacity of 51,200 metric tons. This development signifies a significant expansion for Sudeep Pharma, indicating their commitment to increasing production and meeting growing market demands. The location of the plant in Gujarat, a state known for its robust pharmaceutical industry, further strengthens Sudeep Pharma's position within the sector.